Results 271 to 280 of about 749,314 (382)

Longitudinal monitoring of class‐switched memory‐B cell proportions identifies plausible germinal center failure in patients with suspected immune disorders

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract A reduced proportion of peripheral class‐switched memory B cells (CSM‐B cells) is presumed to indicate ineffective germinal activity. The extent that this finding corresponds to a plausible germinal center failure pathophysiology in patients not diagnosed with CVID or hyper IgM syndrome is not known.
Vijaya Knight, Olivia Starich, Cullen M. Dutmer, Jordan K. Abbott   +3 more
wiley   +1 more source

Acute myeloid leukemia: does sex matter? [PDF]

Leukemia
Tettero JM, Cloos J, Bullinger L.
europepmc   +1 more source

The effects of dexamethasone and tetradecanoyl phorbol acetate on plasminogen activator release by human acute myeloid leukemia cells [PDF]

, 1983
EL Wilson, P Jacobs, EB Dowdle
openalex   +1 more source

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia

Nature Network Boston, 2018
D. Pollyea, Brett M. Stevens, Courtney L Jones, Amanda C. Winters, Shanshan Pei, Mohammad Minhajuddin, A. D’Alessandro, Rachel Culp-Hill, K. Riemondy, A. Gillen, J. Hesselberth, Diana Abbott, Derek Schatz, J. Gutman, E. Purev, Clayton A. Smith, C. Jordan   +16 more
semanticscholar   +1 more source

Methylmalonic acidemia with homocystinuria in acute myeloid leukemia: a case report. [PDF]

BMC Pediatr
Cheng Y, Zhang A.
europepmc   +1 more source

IMBALANCE IN NUCLEOTIDE POOLS OF MYELOID LEUKEMIA CELLS AND HL-60 CELLS: CORRELATION WITH CELL CYCLE PHASE,CELL PROLIFERATION AND DIFFERENTIATION: 53 [PDF]

, 1985
D De Korte, Willem A. Haverkort, Dirk Roos, A. H. van Gennip   +3 more
openalex   +1 more source

Unraveling genotype–phenotype associations and predictive modeling of outcome in acute myeloid leukemia

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Acute myeloid leukemia (AML) comprises 32% of adult leukemia cases, with a 5‐year survival rate of only 20–30%. Here, the immunophenotypic landscape of this heterogeneous malignancy is explored in a single‐center cohort using a novel quantitative computational pipeline.
Artuur Couckuyt, Sofie Van Gassen, Annelies Emmaneel, Vince Janda, Malicorne Buysse, Ine Moors, Jan Philippé, Mattias Hofmans, Tessa Kerre, Yvan Saeys, Sarah Bonte   +10 more
wiley   +1 more source

α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia.

Blood
Millman SE, Chaves-Perez A, Janaki-Raman S, Ho YJ, Morris JP, Narendra V, Chen CC, Jackson BT, Yashinskie JJ, Mezzadra R, Devine TI, Barthet VJA, Saoi M, Baslan T, Tian S, Sachs Z, Finley LWS, Cross JR, Lowe SW.   +18 more
europepmc   +1 more source

Cytarabine-Induced Hyperbilirubinemia in a Pregnant Patient With Acute Myeloid Leukemia. [PDF]

ACG Case Rep J
Rajan A, Ahmed A, Dehghan Y, Hsieh JC, Moore C.   +4 more
europepmc   +1 more source

Diagnostic and Therapeutic Implications of the SUMOylation Pathway in Acute Myeloid Leukemia. [PDF]

Cancers (Basel)
Chatzikalil E, Arvanitakis K, Filippatos F, Diamantopoulos PT, Koufakis T, Solomou EE.   +5 more
europepmc   +1 more source